# E10 Choice of Control Group and Related Issues in Clinical Trials - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/e10-choice-of-control-group-and-related-issues-in-clinical-trials/c5fec9b1-2f5e-4a87-9fda-d276bbfb5cbb

> FDA guidance document: E10 Choice of Control Group and Related Issues in Clinical Trials. Issue date: May 14, 2001. Get complete insights and analysis.

---

## Details

- Title: E10 Choice of Control Group and Related Issues in Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-05-14
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-1874">FDA-1999-D-1874</a>

## Related Documents

- [E2E Pharmacovigilance Planning](https://www.keypedia.com/guidances/guidance-document/e2e-pharmacovigilance-planning/89ea2b55-7e7d-4a99-9e7f-9aac73abf09b)
- [IND Meetings for Human Drugs and Biologics Chemistry, Manufacturing, and Controls Information:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/ind-meetings-for-human-drugs-and-biologics-chemistry-manufacturing-and-controls-information-guidance-for-industry/d36eac77-5bcf-4737-b484-0bdcaf6b5c77)
- [S7A Safety Pharmacology Studies for Human Pharmaceuticals](https://www.keypedia.com/guidances/guidance-document/s7a-safety-pharmacology-studies-for-human-pharmaceuticals/c2197d79-8cb4-464d-8ff4-dbacbcbfef6f)
